AI vs. Journalism
Perplexity AI Faces $30 Million Legal Showdown: Japanese Media Giants Nikkei and Asahi Shimbun Sue for Copyright Infringement
Japanese media titans Nikkei and Asahi Shimbun have filed a lawsuit against AI startup Perplexity AI, accusing them of copyright infringement. The media groups claim Perplexity bypassed safeguards to copy their content without authorization. With $15 million at stake for each party, the case could reshape how AI firms interact with copyrighted media.
Introduction to the Lawsuit
Details of the Alleged Copyright Infringement
Media Groups' Concerns: Credibility and Ethical Issues
Legal Framework: Japan's Copyright Act and Other Precedents
Comparing Similar Lawsuits Against AI Companies
Financial Implications for Perplexity AI
Broader Media Industry Implications
Public Reactions: Support and Concerns
Impact on AI Innovation and Legal Landscape
Future Economic, Social, and Political Implications
Sources
- 1.source(stocktwits.com)
- 2.Japan Times(japantimes.co.jp)
- 3.Kyodo News(english.kyodonews.net)
- 4.Business Standard(business-standard.com)
- 5.source(seobotai.com)
- 6.source(natlawreview.com)
Related News
Oct 29, 2026
Kebbi3 receives Japanese care-technology classification
Marubun’s October 29 announcement concerns a care-technology listing for the AI communication robot. Its TAIS identifier helps buyers check the listed equipment; it does not establish an individual funding award.
Oct 29, 2026
Alexa+ Japan begins rolling invitations, with later pricing and partners still to come
Japan’s October 29 Early Access rollout is free for eligible customers. Rolling invitations, later ¥3,000 monthly pricing and planned local integrations are separate parts of the offer.
Apr 24, 2026
AI Missteps in Healthcare: Lessons From Benjamin Riley's Story
Benjamin Riley's recount of his father's reliance on a flawed AI-generated medical report highlights the dangers of AI in healthcare. Dr. Adam Kittai and Dr. David Bond reveal the report was "nonsense," posing fatal risks. AI's misguided advice emphasizes the need for cautious AI applications, especially in medical circumstances.